In re: Aurobindo Pharma Ltd.

17-115 | U.S. Court of Appeals, Federal Circuit

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed March 3, 2017
Terminated April 20, 2017
Original Case 2:16-cv-00491
Last Updated: 6 years, 11 months ago Show Interactive Timeline
Filing Date # Docket Text
4/27/2017Notice of Correction to the confidential Brief Doc No. [28], Brief Doc No. [27] for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/27/2017 by email. [427683] [Sailesh Patel] [Entered: 04/27/2017 05:48 PM]
4/27/2017Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 28(d) (Briefs) for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/27/2017 by email. [427682] [Sailesh Patel] [Entered: 04/27/2017 05:46 PM]
4/27/201728First Corrected Petition for Writ of Mandamus and Appendix - Confidential Version re-filed pursuant to 04/20/2017 Order, by Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Service: 04/27/2017 by email. [427679] --[Edited 04/28/2017 by clerk to reflect correct document] [Sailesh Patel] [Entered: 04/27/2017 05:44 PM]
4/27/2017First Corrected Petition for Writ of Mandamus and Appendix re-filed pursuant to 04/20/2017 Order, by Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Service: 04/27/2017 by email. [427677] --[Edited 04/28/2017 by clerk to reflect correct document] [Sailesh Patel] [Entered: 04/27/2017 05:41 PM]
4/20/2017
  • OrderDenied
ORDER filed. The petition [2] is denied. (Per Curiam). Service: 04/20/2017 by clerk. [425777] [LS] [Entered: 04/20/2017 10:25 AM]
4/20/2017
  • Motion to FileDenied
ORDER filed. The motion to file under seal [4] is denied. The petition for writ of mandamus offered under seal will remain confidential and thus not viewable by the public. Within 7 days of the date of this order, Petitioners are directed to file corrected confidential and nonconfidential versions of their petition. (Per Curiam). Service: 04/20/2017 by clerk. [425772] [LS] [Entered: 04/20/2017 10:19 AM]
3/24/2017Entry of appearance for Sami Sedghani as of counsel for Respondent Mylan Institutional LLC. Service: 03/24/2017 by email. [418891] [Sami Sedghani] [Entered: 03/24/2017 04:52 PM]
3/24/2017Amended Entry of appearance for Allen F. Gardner as of counsel for Respondent Apicore US LLC. Service: 03/24/2017 by email. [418763] [Allen Gardner] [Entered: 03/24/2017 01:39 PM]
3/24/2017CORRECTED certificate of service for Respondent Apicore US LLC for attorney entry of appearance , Doc No. [20]. Service: 03/24/2017 by email. [418732] [Joanna Goldstein] [Entered: 03/24/2017 01:02 PM]
3/24/201721NOTICE OF DEFICIENCY: The attorney entry of appearance for Attorney Joanna Garelick Goldstein Document No. [20] filed by Respondent Apicore US LLC in 17-115 is indicating more than one principal attorney for the party(s) and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [418698] [CAB] [Entered: 03/24/2017 11:56 AM]
3/24/2017Entry of appearance for Joanna Garelick Goldstein, Esq. as principal counsel for Respondent Apicore US LLC. Service: 03/24/2017 by email. [418673] [Joanna Goldstein] [Entered: 03/24/2017 11:22 AM]
3/22/2017
  • Reply
REPLY of Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to response filed by Respondent in 17-115 , Doc. No [17]. Service: 03/22/2017 by email. [418138] [Sailesh Patel] [Entered: 03/22/2017 06:24 PM]
3/17/2017Notice from Respondent Apicore US LLC and Mylan Institutional LLC Notice of Correction to Response to Petition for Writ of Mandamus. Service: 03/17/2017 by email. [416772] [David Steuer] [Entered: 03/17/2017 07:25 PM]
3/17/2017
  • Response
RESPONSE of Respondent Apicore US LLC and Mylan Institutional LLC to the motion Petition for Writ of Mandamus [2] filed by Petitioners Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-115. Service: 03/17/2017 by email. [416771] [David Steuer] [Entered: 03/17/2017 07:23 PM]
3/17/2017
  • Response
RESPONSE of Respondent Apicore US LLC and Mylan Institutional LLC to the motion Petition for Writ of Mandamus [2] filed by Petitioners Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC in 17-115. Service: 03/17/2017 by email. [416744] [David Steuer] [Entered: 03/17/2017 04:59 PM]
3/17/2017Entry of appearance for Nicole W. Stafford as of counsel for Respondent Mylan Institutional LLC. Service: 03/17/2017 by email. [416660] [Nicole Stafford] [Entered: 03/17/2017 03:13 PM]
3/17/2017Certificate of Interest for the Respondent Mylan Institutional LLC. Service: 03/17/2017 by email. [416621] [David Steuer] [Entered: 03/17/2017 02:24 PM]
3/17/2017Entry of appearance for David S. Steuer as principal counsel for Respondent Mylan Institutional LLC. Service: 03/17/2017 by email. [416618] [David Steuer] [Entered: 03/17/2017 02:23 PM]
3/17/2017Certificate of Interest for the Respondent Apicore US LLC. Service: 03/17/2017 by email. [416524] [Allen Gardner] [Entered: 03/17/2017 10:47 AM]
3/17/2017Entry of appearance for Allen F. Gardner as principal counsel for Respondent Apicore US LLC. Service: 03/17/2017 by email. [416522] [Allen Gardner] [Entered: 03/17/2017 10:45 AM]
3/7/2017
  • Order
ORDER filed. Mylan Institutional LLC and Apicore US LLC are directed to respond to the petition [2] within 10 days from the date of filing of this order. Any reply must be received within five days from the date of filing of the response. (Per Curiam). Service: 03/07/2017 by clerk. [413152] [LS] [Entered: 03/07/2017 04:11 PM]
3/3/2017Certificate of Interest for the Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. Service: 03/03/2017 by email. [412603] [CAB] [Entered: 03/06/2017 09:12 AM]
3/3/2017Entry of appearance for George C. Yu as of counsel for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. Service: 03/03/2017 by email. [412601] [CAB] [Entered: 03/06/2017 09:09 AM]
3/3/2017Entry of appearance for Neil Lloyd as of counsel for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. Service: 03/03/2017 by email. [412600] [CAB] [Entered: 03/06/2017 09:08 AM]
3/3/2017Entry of appearance for Cindy S. Ahn as of counsel for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc.. Service: 03/03/2017 by email. [412599] [CAB] [Entered: 03/06/2017 09:07 AM]
3/3/2017Entry of appearance for Sailesh K. Patel as principal counsel for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc.. Service: 03/03/2017 by email. [412598] [CAB] [Entered: 03/06/2017 09:05 AM]
3/3/2017
  • Motion
MOTION of Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to seal document confidential document [3]. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/03/2017 by US mail, email. [412528] [CAB] [Entered: 03/03/2017 05:05 PM]
3/3/20173Sealed or confidential document received [Petition for Writ of Mandamus pursuant to Fed. R. App. P. 21 - Confidential] (corresponding to Doc No. [2]) for Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 03/03/2017 by US mail. [412527] [CAB] [Entered: 03/03/2017 05:02 PM]
3/3/2017
  • Motion
Petition for Writ of Mandamus pursuant to Fed. R. App. P. 21 filed by Petitioners AuroMedics Pharma LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [Consent: not addressed]. Service: 03/03/2017 by US mail. [412526]--[Edited 03/03/2017 by CB] [CAB] [Entered: 03/03/2017 05:00 PM]
3/3/2017Miscellaneous case docketed. Received: 03/03/2017. [412524]
Entry of Appearance due 03/17/2017. Certificate of Interest is due on 03/17/2017. [CAB] [Entered: 03/03/2017 04:56 PM]